Mechanistically, PTBP1 binds to RALY and together regulates alternative splicing of DNMT3B to increase DNMT3B‐L accumulation, leading to hypermethylation of the DUSP2 promoter and downregulation of its expression, and then increasing radioresistance of prostate cancer. Here, RALY is linked to prostate cancer.